Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Severe Acute Respiratory Syndrome (SARS-CoV). SARS- CoV-2 is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Several known coronaviruses are circulating in animals that have not yet infected humans. 2019 Novel Coronavirus (SARS-CoV-2) is a coronavirus identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. Patients with SARS-CoV-2 report a mild to severe respiratory illness with symptoms of: fever, cough, shortness of breath. There is an urgent need for rapid tests to manage the ongoing pandemic. We are using the Cellex qSARS-CoV-2 IgG/IgM Rapid Test which is intended for qualitative detection of antibodies indicative of SARS-CoV-2 infection and is to be used as an aid for diagnosis of SARS-CoV- 2 infection. The Cellex qSARS-CoV-2 IgG/IgM Rapid Test is a lateral flow immunoassay intended for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in serum, plasma (EDTA, citrate) or venipuncture whole blood specimens from patients suspected of COVID-19 infection by a healthcare provider. The qSARS-CoV-2 IgG/IgM Rapid Test is an aid in the diagnosis of patients with suspected SARS-CoV-2 infection in conjunction with clinical presentation and the results of other laboratory tests.
It is important to note that you may have the virus and still be negative to the immunity test, because it is only testing for immunity to the virus, not actual presence of the virus. If your antibody test is negative, you may be in the early stage (first 3-7 days) of contracting the virus and have not yet created and antibody response to the virus.